CHAMPION-AF study of the WATCHMAN FLX Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
HI-PEITHO trial demonstrates Boston Scientific EKOS Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
